Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02889835 · ClinicalTrials.gov registry record · NA

Clinical Performance of Incremental and Bulk Fill Composites in Class II Restorations

A NA study of Dental Caries, sponsored by Solventum US.

Completed
Registry status
NA
Development phase
53
Enrollment target
1
Study location

NCT02889835 is a NA study of Dental Caries that has completed, run by Solventum US. The registered enrollment target is 53 participants, below the 720-participant average among 30 other Dental Caries trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02889835, a NA study of Dental Caries, has completed, sponsored by Solventum US.

COMPLETED
Registry status
NA
Development phase
53 participants
Enrollment target
1
Study location

Study Summary

This study will examine the clinical performance of Class II restorations over a three year period with 3 composite resins - a conventional composite resin, a flowable composite resin and a bulk placed and cured composite resin.

Conditions Studied

Interventions

  • DEVICE Supreme Universal Restorative
  • DEVICE Supreme Flowable Restorative
  • DEVICE Bulk Fill Flowable Restorative

Study Locations (1)

Alabama

  • University of Alabama at Birmingham Dental School - Birmingham

Trial Details

FieldValue
Enrollment Target 53 participants
Start Date 2016-03-22
Est. Completion 2021-07-03
Phase NA

Sponsor

Solventum US

41 total trials

What the Registry Record Tells You About NCT02889835

The ClinicalTrials.gov registry entry for NCT02889835 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 53 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 720-participant average among 30 other Dental Caries trials with a reported enrollment target (93% lower). The listed sponsor is Solventum US, which has 41 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Dental Caries appearing as the primary indexed condition, and to 3 interventions - of which Supreme Universal Restorative is the first listed.

NCT02889835 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.

Frequently Asked Questions

What is clinical trial NCT02889835 about?

NCT02889835 is a clinical study titled "Clinical Performance of Incremental and Bulk Fill Composites in Class II Restorations". This study will examine the clinical performance of Class II restorations over a three year period with 3 composite resins - a conventional composite resin, a flowable composite resin and a bulk placed and cured composite resin.

What is the current status of trial NCT02889835?

This trial is currently completed. It is a NA study. The enrollment target is 53 participants. The study started on 2016-03-22. Estimated completion is 2021-07-03.

What conditions does trial NCT02889835 study?

This clinical trial studies the following conditions: Dental Caries.

What interventions are being tested in trial NCT02889835?

The interventions under investigation include: Supreme Universal Restorative (DEVICE), Supreme Flowable Restorative (DEVICE), Bulk Fill Flowable Restorative (DEVICE).

Who is sponsoring clinical trial NCT02889835?

This trial is sponsored by Solventum US, which has 41 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02889835 being conducted?

This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Dental Caries

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.